Provided is a naphtyridin compound of Formula (I-A), or pharmaceutically acceptable salt thereof, with defined substituents. The compound is a TLR activity modulator and can be used to treat various diseases (infectious diseases, inflammations, respiratory diseases, dermatological conditions or autoimmune diseases) involving immune system, as the drug is an immune potentiator.